Font Size: a A A

Study On The Therapeutic Status And Case-fatality Rate Analysis Of Hospitalized AMI Patients In 26 Three-level Hospital Of Traditional Chinese Medicine

Posted on:2010-11-08Degree:MasterType:Thesis
Country:ChinaCandidate:J F TianFull Text:PDF
GTID:2144360278951078Subject:Basic Theory of TCM
Abstract/Summary:PDF Full Text Request
Objective: To understand the national-level part of Traditional Chinese Medicine Hospital in 2006 three of the clinical characteristics of AMI patients, the treatment of Chinese and Western medicine and its relationship with prognosis of patients.Methods: With an unified questionnaire, registering part of three national-level hospital for Chinese medicine 1 January, 2006 to December 31 in 2006 patients with AMI discharged from hospital, establishing a database with ACCESS, using statistical software SPSS15.0 to clinices AMI characteristics, treatment conditions described in the impact of mortality and related factors of single-factor and multi-factor analysis.Results:1 his general information on the demographic survey, the overall average age was 65.96±12.44 years old, Which was older 65 years ages accounted for the incidence ratio of 57.13 percent of the total number .Male and female ratio was 1.9:1.In all AMI patients, 516 cases were associated with high blood pressure, the total number of 47.17% of patients, there are 255 cases associated with diabetes, accounting for 23.31% of patients;223 cases are associated with hyperlipidemia, the total number of patients was 20.38%.Patients having coronary heart disease and cerebral stroke, respectively, promoted the total number of patients with 33.36 percent and 38.30 percent.2 TCM Syndrome evidence showed to blood stasis and tanzu were mainly the total number of cases in shizheng , (respectively, 78.1%, 43.0%); qixu and heart yinxue were mainly the total number of cases in xuzheng , (respectively, 62.4%, 21.1 %).3 AMI patients the overall rate of reperfusion therapy was 43.69%. Interference of western medicine: aspirin for the utilization was 91.50%, low molecular weight heparin for the utilization was 83.82%, the utilization rate of Lipid-lowering drugs was 76.14%, the utilization rate of nitrate was 70.66%, than ticlopidine acridine and clopidogrel for the utilization was 66.45%,β-blocker utilization rate was 66.27%, ACEI utilization rate was 66.00%, the utilization rate of unfractionated heparin was 6.58%.4 interference of Chinese medicine: patients have been 946 cases of Chinese medicine formulations of intravenous drip treatment, the total number of cases of 86.47%, the use of the frequency of more than 5% of the Chinese living intravenous injection preparations, Danshen injection preparation category, type of injection Notoginseng solution (Xueshuantong, Xuesaitong), Shenfu injection, Ciwujia, etc.; there are 575 cases of patients with the use of traditional Chinese medicine decoction, the total utilization rate of 52.56 percent, mainly the following law-based governance: Huoxue law, Qi, Huatan law, air law firms; 394 patients using the proprietary Chinese medicines, with a total utilization rate of 36.01%, compound commonly used in Chinese medicines for Aloe soft capsule, soft capsule Cannabis, Tongxinluo Capsule, Compound Danshen Dripping Pills (tablets), oral liquid, such as gas fill the heart.5 A total of all registered cases, 122 cases of death, with a total mortality of 11.15 percent, 101 cases of cardiac death, accounting for 9.23 percent of the number of cases, non-cardiac death in 21 cases, the total number of cases was 1.92%. minimum age was 32-year-old, maximum age was 94-years-old, the average age was 72.96 years old.6 Mortality related to single factor analysis showed that patients with the mortality of the general situation: age, gender, past medical history, with history and situation and certification; and mortality syndrome-related aspects of Chinese medicine are: Yang Permits and certificates of tanzu. Mortality associated with multi-factor analysis revealed that: so that the impact of increased AMI mortality factors (low risk in order) the degree of heart failure increased, sex, age, Deficiency Center Yin, Yang mortality etc.Conclusion:1 In hospital of Chinese medicine and Western medicine hospital in patients with AMI compared with a relatively independent of clinical characteristics: old, high proportion of women, with the disease and complications of multiple characteristics.2 TCM Syndrome evidence showed to blood stasis and tanzuwere mainly the total number of cases in shizheng , (respectively, 78.1%, 43.0%); qixu and heart yinxue were mainly the total number of cases in xuzheng , (respectively, 62.4%, 21.1 %).3 Chinese medicine hospital level reperfusion and drug using in the implementation guide have a greater progress, but the Chinese medicine hospital and the western medicine hospital still exist a certain gap. 4 Chinese Medicine Chinese medicine formulations of intravenous treatment to the main yiqi, activating blood, the treatment Yangyin based mainly on traditional Chinese medicine decoction Huoxue law, yiqi, Huatan law-based, supporting the proprietary Chinese medicines Compound Aloe Soft Capsule , seed soft capsule, Tongxinluo Capsule, Compound Danshen Dripping Pills (Tablets), fill the heart, such as the treatment of oral liquid gas.5 Studies showing mortality: age, the higher mortality rate; At the same time, more women than men for the high fatality rate; previous cardiovascular and cerebrovascular diseases, hypertension, diabetes, hyperlipidemia, clinical complications (including arrhythmia, heart failure, infarction postinfarction angina, etc.) were highly correlated with mortality; TCM Syndrome, the display card and tanzu positive evidence from the differences associated with mortality; multi-factor analysis showed that the clinical data of patients with AMI admitted to hospital increased the impact of mortality factors are: the degree of heart failure increased, sex, age, deficiency of heart-yin etc. dyslipidemia and tanzu needed to be studied further.6 Through this study with the same subject in 2000, and 2005, Comparative study in Beijing found that Chinese medicine hospitals in the treatment of acute myocardial infarction have made gratifying progress, but acute myocardial infarction to reduce mortality is still a long way to go work. Accompanied by the deepening of the topic, and reperfusion in the capacity of a hospital for Chinese medicine, Chinese medicine treatment and characteristics of the standardization will have to play even greater progress.
Keywords/Search Tags:China, Acute myocardial infarction, therapeutic status, case-fatality rate
PDF Full Text Request
Related items